Replacement

Replacement Therapeutics is a biotechnology company focused on developing bio-artificial organs and regenerative medicine solutions to address the shortage of donor organs. The company's primary focus is on creating functional, implantable replacement tissues and organs using advanced cell therapy and tissue engineering techniques. Their lead programs aim to provide alternatives for patients suffering from liver failure and end-stage renal disease. By leveraging proprietary cell-seeding and scaffold technologies, Replacement Therapeutics seeks to restore physiological function without the need for lifelong immunosuppression. The company is currently in the pre-clinical stage, refining its bio-artificial constructs for future human clinical trials.